纤维化间质性肺疾病的早期诊断:挑战与机遇
纤维化间质性肺疾病(ILD)患者常因症状非特异、首诊医生认知不足而诊断延迟,导致生活质量下降和早期死亡。本文讨论患者与医生在早期诊断中面临的挑战,探索在普通人群和高危个体中促进早期识别的策略,并探讨筛查项目的争议与不确定性。及时识别和准确诊断虽面临临床挑战,但可能通过早期启动适当管理改善结局。
要点
- 纤维化ILD诊断延迟常见,导致不必要、昂贵或有创的检查及无效甚至有害的治疗。
- 症状非特异隐匿及基层与非ILD专家认知不足是诊断延迟的主要原因。
- 早期识别高危个体并及时诊断可能通过早期适当管理改善结局。
核心结论
- 纤维化ILD的及时识别和准确诊断面临重大临床挑战,但可能通过早期启动适当管理改善结局。
研究设计与样本
- 本文为综述,讨论纤维化ILD早期诊断的挑战与机遇,并探讨筛查项目的争议与关键不确定性。
主要发现
- 纤维化ILD患者常存在相当程度的诊断延迟,并暴露于不必要和昂贵的诊断程序以及无效且可能有害的治疗。
- 症状非特异且隐匿,加上基层医生和非ILD专家对纤维化ILD知识匮乏,是诊断延迟的主要原因之一。
临床怎么用
- 应关注纤维化ILD的早期识别,在普通人群和高危个体中探索促进早期识别的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Many patients with interstitial lung disease (ILD) develop pulmonary fibrosis, which can lead to reduced quality of life and early mortality. Patients with fibrotic ILD often have considerable diagnostic delay, and are exposed to unnecessary and costly diagnostic procedures, and ineffective and potentially harmful treatments. Non-specific and insidious presenting symptoms, along with scarce knowledge of fibrotic ILD among primary care physicians and non-ILD experts, are some of the main causes of diagnostic delay. Here, we outline and discuss the challenges facing both patients and physicians in making an early diagnosis of fibrotic ILD, and explore strategies to facilitate early identification of patients with fibrotic ILD, both in the general population and among individuals at highest risk of developing the disease. Finally, we discuss controversies and key uncertainties in screening programmes for fibrotic ILD. Timely identification and accurate diagnosis of patients with fibrotic ILD poses several substantial clinical challenges, but could potentially improve outcomes through early initiation of appropriate management.
引用
- Spagnolo P, Ryerson CJ, Putman R, et al. Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities. Lancet Respir Med. 2021. PMID: 34331867. doi:10.1016/S2213-2600(21)00017-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。